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years bear a potential for arrhythmias, atrial fibrillation or 
a 20-fold higher possibility of SCD than female athletes. 
Ruwald et al. [6] showed recently in the European Heart 
Journal (EHJ, April 2015) that competitive sport is associ-
ated with a twofold increased risk of ventricular arrhyth-
mias/death when compared with inactive patients and with 
patients who participated in recreational sport. When com-
pared with inactive patients, recreational sport was not asso-
ciated with an earlier onset of symptoms or increased risk 
of ventricular arrhythmias/death. Therefore, the question 
arises how to prevent these events in competitive sports, 
even if they are relatively rare. Do these events justify the 
use of all our medical armamentarium, in particular, an ECG 
or even an exercise ECG?
In Italy in 2006, Corrado et al. [7] were able to show a 
reduction in the incidence of sudden cardiac death due to the 
screening intervention and appropriate restriction of athletes 
with arrhythmogenic right ventricular dysplasia. Can these 
results be extrapolated to other countries [8]? Perhaps it is 
best to focus on some achievable goals in pre-participation 
screening: (1) identify individuals known to be at risk and 
allow stratification of these risks, and (2) make recommen-
dations regarding participation.
In 2011, the Journal of the American College of Cardiol-
ogy (JACC) featured an article entitled ‘Mandatory Elec-
trocardiographic Screening of Athletes to Reduce Their 
Risk for Sudden Death: Proven Fact or Wishful Think-
ing?’, which suggests the latter [9]. The study analysed 
the incidence of sudden death among competitive athletes 
following the enactment of the 1997 USA National Sport 
Law, which mandates screening of all athletes with resting 
ECG and exercise testing. The average yearly incidence of 
sudden death or cardiac arrest events was 2.6 events per 
100,000 athlete-years. The study concluded that mandatory 
ECG screening of athletes had no apparent effect on their 
In April 2015, it was reported by the San Antonio Express-
News (Texas, USA) that legislation, requiring that high 
school student athletes should undergo electrocardiographic 
(ECG) screening before participating in sports, passed with 
a clear majority through a second reading in the Texas 
House. At the same time, The Dallas Morning News pointed 
out that the American College of Cardiology (ACC) and the 
Texas Pediatric Society were against the measure.
There are few topics that lead to more controversy 
amongst physicians caring for young athletes than the cor-
rect method of pre-participation physical screening. On one 
hand, there is the conviction that physical screening has lim-
ited use if the end result is the final common pathway, that 
is unstable ventricular arrhythmias [1]; on the other hand, 
there is the belief that all young athletes, regardless of the 
sport and level of participation, require history, physical 
examination, (stress) ECG, echocardiography and, if nec-
essary, even magnetic resonance imaging and computed 
tomography [2, 3].
What fuels such debates is the fact that sudden cardiac 
death (SCD) in the young athlete is estimated to occur in 
between 0.5 and 1 per 100,000 participating athletes below 
the age of 35 years [4]. In the USA, 50–75 deaths per year 
occur in young athletes; in France, this is approximately 
10–15 [5]. Although these are very low numbers, it should 
be realised that competitive young male athletes suffer 
a fivefold higher risk of sudden cardiac death than non-
competitive athletes, and male athletes aged more than 30 
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risk of cardiac arrest. The authors suggested that the higher 
incidence of sudden death found in the Italian studies was 
not representative of the sudden death risk in the athlete 
population of most other countries and continents, which 
have a much lower incidence.
When considering the current guidelines and recommen-
dations, there is a disparity between Europe and the USA 
regarding the advice one should follow. Both the ACC and 
the American Heart Association (AHA) still agree that the 
mandatory screening of all young athletes with an ECG 
is not warranted based on cost due to the large number of 
tests that would be required, the low incidence of sudden 
death among athletes in the USA as well as the concern 
for false-positive results. Proceedings of the ACC Sports 
and Exercise Cardiology Think Tank, Washington, DC, on 
18 October 2012 (published in JACC, November 2014), 
reported that, before changes in screening programs are rec-
ommended in the USA, data should be acquired that can 
demonstrate an improved outcome in young, asymptomatic 
athletes and show that the benefit of screening outweighs 
the risks [10]. By contrast, both the European Society of 
Cardiology (ESC) and the International Olympic Commit-
tee (IOC) have an  opposing view and recommend resting 
electrocardiograms for all young athletes before they are 
allowed to compete [11]. The ESC and IOC points of view 
appear to now be in line with the recent legislation bill in 
Texas, USA, requiring that high school students should 
undergo ECG screening before participating in sports.
This verdict is corroborated by a recent study from Leis-
chik et al. [12] stating that there is a basic need for indicated 
examinations and/or preventive measures inside or outside 
of pre-competition screening, both for young and older ath-
letes (< 35 and > 35 years). Competitive ambitious athletes 
< 35 years  should undergo a specific cardiological exami-
nation including echocardiography and exercise test, and 
regular annual check-up examinations if problems occur 
and before starting a training session. This policy largely 
supports the Lausanne protocol (revised in 2013), followed 
by our national Society of Sports Medicine (VSG), advo-
cating a 12-lead resting ECG in ‘top sportsmen’ < 35 years 
of age (http://www.sportgeneeskunde.com/richtlijnen-vsg). 
Athletes > 30 years of age, undergoing extreme endurance 
competition, for example, triathlon or marathon, should 
preferably be examined by stress echocardiography from a 
prognostic point of view [13]. According to the authors [12], 
the costs for screening examinations should be regarded 
as negligible, given the high expenditures for preparation 
and participation in marathon and triathlon competitions 
or intensive costs in professional football and other team 
sports. Prevention of sudden sport-related deaths does not 
only have an individual component, but also a significant 
social impact on physical activity in the general population. 
In this regard, further expenses, studies and well-founded 
pre-competition screening in the industrialised world are 
socially justified and financially reasonable. The authors 
clearly affirm that the long-lasting disputes about using 
resting-ECG in pre-competitive sport screening belong to 
the past and that exercise tests should not only be reserved 
for professional teams.
To conclude, recent strategies, in particular based on 
European studies, seem to be in favour of routinely per-
forming ECG screening in all athletes involved in com-
petitive sports activities, irrespective of age and (family) 
history. This policy has, of course, the necessary implica-
tions for the present pre-participation screening. To further 
improve pre-participation screening, a dedicated education 
and certification program on 12-lead ECG interpretation is 
needed [14, 15]. Standardised screening tools that include 
screening and interpretation of both resting and exercise 
ECGs for targeted athlete populations at risk of SCD are 
required [16]. These recommendations are aimed to over-
come the resistance raised by individuals and institutions to 
pre-participation screening with an ECG.
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